Ikarian Capital, LLC Eledon Pharmaceuticals, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.45 - $3.88 $344,732 - $545,943	-140,707 Reduced 38.81%	221,830 $612,000
Q1 2022 May 13, 2022	BUY	$3.06 - $4.89 $54,954 - $87,819	17,959 Added 5.21%	362,537 $1.43 Million
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.46 $32,206 - $45,870	-5,422 Reduced 1.55%	344,578 $2.13 Million
Q2 2021 Aug 16, 2021	BUY	$7.62 - $11.75 $762,000 - $1.18 Million	100,000 Added 40.0%	350,000 $2.77 Million
Q1 2021 May 17, 2021	BUY	$9.85 - $19.22 $2.46 Million - $4.81 Million	250,000 New	250,000 $2.68 Million

18.4M

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $60M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.